COMPANY 

INSIGHT

Sponsored by

High precision, low friction and low energy consumption

With headquarters located in Biel/Bienne Switzerland, MPS Micro Precision Systems AG develops and manufactures highly complex and very precise mechanical and electro-mechanical microsystems used in the Medtech, Automation and Watch industries.

In a spacious and modern architecture the 400 employees of MPS transform customer requirements and specifications into robust and reliable products and systems.

MPS supplies to a Blue Chip Medtech company in the US the dosing system for a programmable implantable infusion pump. The pump’s main requirement is to deliver a specific amount of medication using the energy stored in an embedded battery. To guarantee this requirement over the entire lifetime of the product (7 years), MPS has optimised a very precise implantable microsystem which performs the function with nearly no friction and therefore minimal energy consumption.

MPS Microsystems produces a system for a programmable implantable infusion pump (AIMD Class 3) that consumes low level of energy, that is biocompatible and also corrosion-resistant.
In close collaboration, MPS Microsystems produces a miniature and extremely accurate hexapod robot. This tool assists surgeons and offers them accurate positioning and movement during spine operations

Spine surgery is a very delicate operation, with success depending on the individual performance of the surgeon. MPS manufactures a small and very precisely adjustable spine surgery assist robot (positioning precision = 1µm), which makes the accuracy of the surgical procedure less dependent on the surgeon’s daily performance.

Biocompatible actuators

MPS’ biocompatible actuator technology consists of an encapsulated motor, electronics and power element, as well as a gearbox and leadscrew made of biocompatible materials. The actuators and electronics are designed for long term implantation and for wireless data and energy transfer. This technology has a wide range of applications in the orthopaedic, spine, CMF, urology and other markets.

Micro Robotics

Integrating as much functionality as possible into the smallest available space is a key competence of MPS and a requirement of the market for active implants. MPS engineers are combining their know-how in micro bearing technologies, the know-how of their parent company Faulhaber in micro motors and gear boxes and the competences of their electronic partner in order to develop and manufacture implantable, intelligent microsystems featuring low energy consumption.

Very high precision component manufacturing and system assembly in clean environment

Very precise components are at the heart of MPS’ microsystems. These components are manufactured at MPS own workshops in Biel/Bienne: Swiss turning, flat, round and centerless grinding as well as polishing yield components with tolerances lower than 1µm and to a surface roughness of less than 0.1 Ra. MPS is also well equipped for heat treatment and component cleaning.

Very impressive are MPS’s microsystems assembly capabilities: in order to reach the required repeatable precision and the lowest possible friction by keeping system stiffness, MPS has developed its own assembly processes and capabilities. Using MPS made assembly benches and jigs, the operators pair components to a precision of less than 0.2 µm in series production. Depending on the requirements, system assembly is taking place either in a dust free room or in a clean room ISO class 7.

Technical files

MPS project / product documentation conform to CE standards, 510k and PMA requirements. MPS customers may use this documentation to complete their submission dossier.

Orthopaedic instruments

Since December 2012 MPS has a new subsidiary named “MPS Precimed”. It is located in Bienne in the same facilities than MPS Micro Precision Systmes AG. With its 40 employees, MPS Precimed develops and manufactures innovative orthopaedics instruments for the main Blue Chip orthopaedic companies. Reamers, impactors and drills are part of MPS Precimed’s product portfolio.

Go to article: Home | Testing for trauma Go to article: In this issueGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Contents Go to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: NewsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: The Medical Industry Briefing Go to article: Picosun Company Insight Go to article: PicosunGo to article: Transvaginal mesh timeline: the gynaecological scandal that rocked the worldGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Unwrapping the FDA’s voluntary programme for medical devicesGo to article: ARPA Company InsightGo to article: ARPAGo to article: Reversing Alzheimer’s-related memory loss with electromagnetic wavesGo to article: MikronGo to article: New England Wire TechnologiesGo to article: Medical devices: redesigning for success Go to article: Siemens Company Insight Go to article: Siemens Go to article: Moving medical supplies: enter the droneGo to article: 3BYGo to article: iTAC SoftwareGo to article: A diagnostic tool for respiratory disease: machine learning coughs up Go to article: CarmoGo to article: Medicoat Go to article: Blood will tell: a new diagnostic approach for PTSDGo to article: Bright PlasticsGo to article: Cap BiomaterialsGo to article: Is AI paving the way to doctorless diagnosis?Go to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: Robotic colectomy may have limited safety benefitsGo to article: Maraca InternationalGo to article: mdi ConsultantsGo to article: Wearable digital interventions make inroads for autistic childrenGo to article: ProByLas Go to article: SartoriusGo to article: Robots are making significant inroads into surgeryGo to article: EuroquartzGo to article: Euroquartz Company InsightGo to article: Google’s $2.1bn Fitbit purchase raises cybersecurity anxiety levelsGo to article: Tech NHGo to article: US regulator approves first contact lens to slow the onset of myopia in childrenGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Deals in brief powered by GlobalDataGo to article: CleanControlling MedicalGo to article: The key list powered by GlobalDataGo to article: UNI-FABGo to article: EventsGo to article: Medica Company Insight Go to article: Medica Go to article: Next issue